Medisafe 1 Technologies Obtains Listing on Berlin Stock Exchange

JERUSALEM, September 24, 2012 /PRNewswire/ --



Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's common stock became eligible for trading on the Borse Berlin, or the Berlin Stock Exchange, under the symbol "MS1" and the German security number (WKN) "A1JPAQ".

The Berlin Stock Exchange has secondary stock listings for over 6,000 U.S. securities that are listed on such exchanges as the NYSE, NASDAQ, AMEX or quoted on the OTC Bulletin Board.

"Trading shares on the Berlin exchange provides Medisafe 1 Technologies with increased exposure to the European capital markets," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We are hopeful that access to additional investment capital can increase the company's capabilities to further develop and market our proprietary, life-saving devices."


About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle.  Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Jacob Elhadad CEO
+972-524440000
Jacob.elhadad10@gmail.com

SOURCE Medisafe 1 Technologies Corp.




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.